Images
Participants
Contact
La Vanguardia, Cope, Revista Genética, among other media, have each published an article about the latest study led by ICREA researchers Salvador Aznar Benitah and Fran Supek. The study warns that special care should be taken regarding epigenetic therapies since although their anti-tumour effect may be beneficial initially, they can trigger the development of more aggressive tumours later on.
Link to La Vanguardia
Link to Cope
Link to Revista Genética
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
